RARE vs WSR · rev $350.0M vs P/E 20, rev $160.9M
Ultragenyx (RARE) versus Whitestone REIT (WSR) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Whitestone REIT (WSR) is a reit - retail company listed on NYSE.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported WSR revenue for 2025-12-31 was $160.9M. Net income was $49.9M. Revenue was up 293.9% from 2024-12-31 to 2025-12-31. WSR currently screens at market cap $984.4M and trailing P/E 19.7.
RARE currently screens at market cap $2.79B. WSR currently screens at market cap $984.4M and trailing P/E 19.7.
Not investment advice. Open the RARE and WSR stock pages for the full models.
Not investment advice.